Trial intelligence / Profile preview

Hamstring graft donor site bupivacaine infiltration for pain relief after ACL reconstruction

2006-001556-12Phase 4Terminated

Sponsor
University Hospitals of Derby and Burton
Start
Apr 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of bupivacaine in anterior cruciate ligament injury (2 arms), sponsored by University Hospitals of Derby and Burton. Primary endpoint: Pain relief at hamstring donor site in first 24 hours. Started Apr 2006; status: terminated.

02

Drugs

bupivacaine
03

Conditions

anterior cruciate ligament injury

Beyond the preview

Go deeper on 2006-001556-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001556-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call